Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: Italy Clear all

197 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20021
20041
20051
20062
20077
20087
200911
20107
20118
20128
20137
20146
20157
20165
20177
201811
201918
20204
202116
202212
202318
202410
20258
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed96
Recruiting37
Unknown status22
Active, not recruiting20
Terminated16
Not yet recruiting5
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer14
IRCCS Azienda Ospedaliero-Universitaria di Bologna12
Fondazione Policlinico Universitario Agostino Gemelli IRCCS11
AstraZeneca7
Bristol-Myers Squibb7
Hoffmann-La Roche7
University of Milan6
Istituto Clinico Humanitas5
Eli Lilly and Company4
Exelixis4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular197
Liver Neoplasms39
Neoplasms19
Colorectal Neoplasms12
Fibrosis11
Carcinoma, Non-Small-Cell Lung10
Stomach Neoplasms10
Liver Cirrhosis9
Carcinoma8
Liver Diseases8

Trials

Showing 76 to 100 of 197. Each trial links to its page on Pharma Observatory.

97 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.